Kiezen voor de juiste benzodiazepine:werkingsmechanisme en farmacokinetiek

التفاصيل البيبلوغرافية
العنوان: Kiezen voor de juiste benzodiazepine:werkingsmechanisme en farmacokinetiek
المؤلفون: Vinkers, Christiaan H, Tijdink, Joeri K, Luykx, Jurjen J, Vis, Roeland
المصدر: Vinkers, C H, Tijdink, J K, Luykx, J J & Vis, R 2012, ' Kiezen voor de juiste benzodiazepine : werkingsmechanisme en farmacokinetiek ', Nederlands Tijdschrift voor Geneeskunde, vol. 155, no. 35, pp. A4900 .
سنة النشر: 2012
مصطلحات موضوعية: Anti-Anxiety Agents/pharmacokinetics, Kinetics, Treatment Outcome, SDG 3 - Good Health and Well-being, Area Under Curve, Benzodiazepines/pharmacokinetics, Anxiety/drug therapy, Humans, Half-Life
الوصف: There is a discrepancy between the recommendation for caution and daily practice in the prescription of benzodiazepines. Although there is heterogeneity in the registered indications, all benzodiazepine agonists have almost the same mechanism of action. There are, however, substantial pharmacokinetic differences between individual benzodiazepine agonists. During short-term use of benzodiazepines, the elimination half-life is no measure of duration of action. Benzodiazepine lipophilicity determines the speed of action. If a rapid effect is desired, for instance in acute anxiety or agitation, then regarding oral medication the use of a lipophilic benzodiazepine such as diazepam is a rational choice. An accumulation factor can be used to estimate benzodiazepine accumulation during chronic use. In theory, accumulation does not occur with once-daily dosage of benzodiazepines that have an elimination half-life markedly shorter than 24 h, such as oxazepam, temazepam, and lorazepam.
اللغة: Dutch; Flemish
URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0ddf0b0d510ca0b2bdc0f0eb53206215
https://hdl.handle.net/1871.1/09f5194c-e7c2-4536-a724-0abcb96a619a
حقوق: RESTRICTED
رقم الأكسشن: edsair.dedup.wf.001..0ddf0b0d510ca0b2bdc0f0eb53206215
قاعدة البيانات: OpenAIRE